Does low testosterone affect adaptive properties of adipose tissue in obese men

Archives of Physiology and Biochemistry

Volumn 117, Issue 1, 2011, Pages 18-22

  Ruige, Johannes B ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adipose tissue; Obesity; Steroids; Type 2 diabetes mellitus

Indexed keywords

ESTRADIOL; INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADAPTATION; ADIPOSE TISSUE; BLOOD; BODY MASS; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ADAPTATION, PHYSIOLOGICAL; ADIPOSE TISSUE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; ESTRADIOL; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 78651244110     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2010.525239     Document Type: Review

References (48)

1. Anderson LA, McTernan PG, Barnett AH, Kumar S. (2001). The effects of androgens and oestrogens on preadipocyte proliferation in human adipose tissue: infuence of gender and site. J Clin Endocrinol Metab 86(10):504-51.
2. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. (2007). Effects of two years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance and postprandial glucose turnover in elderly men. Diabetes Care 30(8):1972-8.
3. Blouin K, Veilleux A, Luu-The V, Tchernof A. (2009). Androgen metabolism in adipose tissue: Recent advances. Mol Cell Endocrinol 301(1-2):97-103
4. Bolduc C, Larose M, Yoshioka M, Ye P, Belleau P,Labrie C, Morissette J, Raymond V, Labrie F and St-Amand J (2004). Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol 33(2):429-44.
5. Colangelo LA, Ouyang P, Liu K, Kopp P, Golden SH, Dobs AS, Szklo M, Vaidya D, Cushman M, Gapstur SM (2009). Associations of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care 32(6):1049-51.
6. Crisafulli C, Bruscoli S, Esposito E, Mazzon E, Di Paola R, Genovese T, Bramanti P, Migliorati G, Cuzzocrea S. (2009). PPAR-alpha contributes to the anti-inflammatory activity of 17beta-oestradiol. J Pharmacol Exp Ther 331(3):796-807.
7. Dicker A, Rydén M, Näslund E, Muehlen I, Wirén M, Lafontan M, Arner P. (2004). Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 47(3):420-28.
8. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. (2000). Opposite effects of androgens and oestrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferators-activated receptor gamma2. Endocrinology 141(2):649-56.
9. Du J, Zhang L, Wang Z. (2009). Testosterone inhibits the activity of peroxisome proliferator- activated receptor gamma in a transcriptional transaction assay. Pharmazie 64(10):692-3.
10. Elbers JM, Asscheman H, Seidell JC, Gooren LJ. (1999) Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol 276(2 Pt 1):E317-25.
11. Frayn KN. (2002). Adipose tissue as a buffer for daily lipid flux. Diabetologia 45(9):1201-10.
12. Gooren LJ, Giltay EJ, Bunck MC. (2008). Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93(1):19-25.
13. Garcia E, Lacasa M, Agli B, Giudicelli Y, Lacasa D. (1999). Modulation of rat preadipocyte adipose conversion by androgenic status: involvement of C/EBPs transcription factors. J Endocrinol 161(1):89-97.
14. Gregoire FM, Smas CM, Sul HS. (1998). Understanding adipocyte differentiation. Physiol Rev 78(3):783-809.
15. Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, Choong K, Tchkonia T, Lebrasseur NK, Flanagan JN, Hamilton JA, Viereck JC, Narula NS, Kirkland JL, Jasuja R (2008). Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol 296(1-2):32-40.
16. Haring R, Völzke H, Felix SB, Schipf S, Dörr M, Rosskopf D, Nauck M, Schöfl C, Wallaschofski H. (2009). Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58(9):2027-31.
17. Heufelder AE, Saad F, Bunck MC, Gooren L. (2009). Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 30(6):726-33.
18. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y. (2000) Oestrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique oestrogen response element on the lipoprotein lipase promoter. J Biol Chem 275(15):11404-11.
19. Khaw KT, Barrett-Connor E. (1992). Lower endogenous androgens predict central adiposity in men. Metab Ann Epidemiol 2(5):675-82.
20. Klinge CM. (2008). Oestrogenic control of mitochondrial function and biogenesis. J Cell Biochem 105(6):1342-51
21. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, Salonen JT. (2005). The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90(2):712-19.
22. Lapauw B, TSjoen G, Mahmoud A, Kaufman JM, Ruige JB. (2009). Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men. Eur J Endocrinol 160(3):397-402.
23. Lissner L, Björkelund C, Heitmann BL, Seidell JC, Bengtsson C. (2001). Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 9(10):644-6.
24. Lu C, Kumar PA, Fan Y, Sperling MA, Menon RK. (2010). A novel effect of growth hormone on macrophage modulates macrophage- dependent adipocyte differentiation. Endocrinology 151(5):2189-99.
25. Mårin P, Odén B, Björntorp P. (1995). Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80(1):239-43.
26. Mårin P, Lönn L, Andersson B, Odén B, Olbe L, Bengtsson BA, Björntorp P. (1996). Assimilation of triglycerides in subcutaneous and intra-abdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab 81(3):1018-22.
27. Manolopoulos KN, Karpe F, Frayn KN. (2010). Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 34(6):949-59.
28. McIntosh M, Hausman R, Martin R, Hausman G. (1998). Dehydroepianodrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells. Am J Physiol 275:E285-95
29. Monjo M, Pujol E, Roca P. (2005). α2- to β3-adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17β-oestradiol, and progesterone. Am J Physiol Endocrinol Metab 289:E145-50
30. Morita J, Hakuno F, Hizuka N, Takahashi S, Takano K. (2009). Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates. Endocr J 56(4):561-70.
31. Pilz S, März W. (2008). Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med 46(4):429-34.
32. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ. (2005). Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 90(5):2636-41.
33. Price TM, OBrien SN, Welter BH, George R, Anandjiwala J, Kilgore M. (1998). Oestrogen regulation of adipose tissue lipoprotein lipase - possible mechanism of body fat distribution. Am J Obstet Gynecol 178(1 Pt 1):101-7.
34. Raven G, de Jong FH, Kaufman JM, de Ronde W. (2006). In men, peripheral estradiol levels directly reflect the action of oestrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 5(9):3324-8.
35. Rodríguez-Cuenca S, Monjo M, Gianotti M, Proenza AM, Roca P. (2007). Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17beta-estradiol, testosterone, and progesterone. Am J Physiol Endocrinol Metab 292(1):E340-6.
36. Ruige JB, Van Gaal LF (2009). Low fasting triglycerides: hallmark of the healthy large hip? Obesity (Silver Spring) 17(8): 1621-6.
37. Santosa S, Jensen MD. (2008). Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab 295(3):E531-5.
38. Sharma AM, Staels B. (2007). Review: Peroxisome proliferators- activated receptor gamma and adipose tissue - understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92(2):386-95.
39. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S. (2006). Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147(1):141-54.
40. Stefan N, Kantartzis K, Machann J et al. (2008). Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-16.
41. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. (2000). Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23(4):490-94.
42. Tsai EC, Boyko EJ, Leonetti DL, Fujimoto WY. (2000). Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord 24(4):485-91.
43. Vermeulen A, Kaufman JM, Giagulli VA. (1996). Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81(5):1821-6.
44. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. (2002). Oestradiol in elderly men. Aging Male 5(2):98-102.
45. Wajchenberg BL. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738.
46. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. (2005). Use of waist circumference to predict insulin resistance: retrospective study. BMJ 330(7504):1363-4.
47. Wu Z, Rosen ED, Brun R et al. (1999). Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3:151-8.
48. Zitzmann M. (2009). Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5(12):673-81.